reference/20758146

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20758146

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Research Support, N.I.H., Extramural
endingPage	475
issn	1573-0646 0167-6997
issueIdentifier	5
pageRange	469-475
publicationName	Investigational New Drugs
startingPage	469
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3db334f5c423ff64c07145362720edc1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_10811a9fce90928993b139c63e9bdeb2 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ae8c88da36d0c2b3c263ac03eaceaf43 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6e9cb5cbe620f5c2637a1720b95437c6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2eb4f934e42db7f520a375beecbc69f7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_80d17e149ec64dc1011ef3b4a65bd408 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cb6a3992b94109d7cec89fb7bac9a5f8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b41de81dedb5747678cc9e75e3428327 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_76c40ee5990e538cfdb4f601bc259207 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d15257efeaf81fa7f3e4037775609c30 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8fd6b1e8cbcd99b1a472e6fa9aacafed http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8a16b64db9b46d0fc5d4a1b9a654fac5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_88b345a1bc85431c07022458b644f6c2 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9e05e4b230f5a9892f3120f401e7bbd5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_953c9b7a2b5ab9b00f1cf178e1f591b9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c763d3e50ce1a589b4b07893a8260a45 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_adb9f7baabcd3726db4f24ba80e3eb53 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c5d74a492ae8b461708e0ecdd8507705 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_31d2af91e8202489f2ca5d4b5cdb7935 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_33605f6d1a3e4561ee69fa452f8545ca http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b3eb645e9cd0db5cec6c05ec8f2cadfe http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1e6bf8fb064148db85cb11b3b1e6ceca http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_317f34bfd3a0207a06adf619b708bca5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3438781332dc95b03df0e50cae90f02d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c6d110cf18f826b8304e19c6162ac9d1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c2190ef40e8b110643cbd0a0f6576689 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6732e401ae85a71024773f3b46d547c7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b5cd57bc6bd8da322fe79415d176562e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4604dea4dadbc0a6b00b2249733f11c5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_981abbd7948e732d2d056220a9792adc
bibliographicCitation	Whitehead RP, Rankin C, Hoff PMG, Gold PJ, Billingsley KG, Chapman RA, Wong L, Ward JH, Abbruzzese JL, Blanke CD. Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336). Investigational New Drugs. 2008 Oct 22;27(5):469. doi: 10.1007/s10637-008-9190-8.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_702c25ab0f4ff577035c73fad4797edd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13a03b84c8062a4733c99694264f5854 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17c599ae5e081b5e4975888ce700bc74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b84f91f17ff1a35ccc7a81b40bee4a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7891d08f5d6bdd4853ec3208d8130d44 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf713397ab944475b3b846efa6f51d00 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fcf35e4fd5e41dfbb1c2028b9a824b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2753e0d8506768e9375c01cbe3fd39a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cbd34333224ec6330a0cbdeb073138a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7ca5d06336d6c5ce25b1c53b1c3f764
date	2008-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC3024913 https://doi.org/10.1007/s10637-008-9190-8 https://pubmed.ncbi.nlm.nih.gov/18941712
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4372 https://portal.issn.org/resource/ISSN/1573-0646 https://portal.issn.org/resource/ISSN/0167-6997
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
discusses	http://id.nlm.nih.gov/mesh/M0458175 http://id.nlm.nih.gov/mesh/M0001348 http://id.nlm.nih.gov/mesh/M0519758
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.5.1.98 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6910 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5352062 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7920 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248745162

Total number of triples: 75.